{"id":49925,"date":"2022-10-21T18:02:12","date_gmt":"2022-10-21T16:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/"},"modified":"2022-10-21T18:02:12","modified_gmt":"2022-10-21T16:02:12","slug":"global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/","title":{"rendered":"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624593\/global-non-cancerous-blood-disease-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f2z27n&amp;utm_campaign=1765630+-+Global+Non-Cancerous+Blood+Disease+Market+Report+2022%3A+Growing+Need+for+the+Early+Diagnosis+of+Different+Types+of+Non-Cancerous+Blood+Diseases+Driving+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Non-Cancerous Blood Disease Market Analysis 2021-2031&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global non-cancerous blood disease market is anticipated to grow with a CAGR of 6.40% over the forecast period, 2022 &#8211; 2031.\n<\/p>\n<p>\nFactors such as the growing need for the early diagnosis of different types of non-cancerous blood diseases, followed by the surge in the burden for hemoglobinopathies across the globe, are anticipated to drive the growth of the market in the coming years.\n<\/p>\n<p>\nAdditionally, the increasing prevalence of non-cancerous blood disorders globally, along with the growing research and development in this field, followed by the surge in expenditure on R&amp;D activities are also expected to boost the market growth in the coming years. The market is estimated to garner a revenue of near to USD 105970 Million by the end of 2031, up from a revenue of more than USD 57220 Million in the year 2021.\n<\/p>\n<p>\nThe global non-cancerous blood disease market is segmented into numerous segments, which include segmentation by disorder type, treatment type, gender, end-user, and by region.\n<\/p>\n<p>\nBy disorder type, the market is segmented into anemia, bleeding disorders, platelet disorders, white blood cell disorders, plasma cell disorders, rare hematological disorders, and spleen disorders.\n<\/p>\n<p>\nBy the end of 2031, the bleeding disorders segment is projected to display the largest revenue of close to USD 29950 Million, up from a revenue of about USD 16570 Million in the year 2021.\n<\/p>\n<p>\nOn the basis of regional analysis, the global non-cancerous blood disease market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East &amp; Africa region. The market in Europe region, out of the market in all the other regions, is anticipated to garner the largest revenue of over USD 39840 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of around USD 21340 Million.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Market Definition and Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>2. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>3. Market Dynamics<\/strong>\n<\/p>\n<p>\n<strong>4. Key Market Opportunities<\/strong>\n<\/p>\n<p>\n<strong>5. Major Roadblocks for the Market Growth<\/strong>\n<\/p>\n<p>\n<strong>6. Regulatory &amp; Standards Landscape<\/strong>\n<\/p>\n<p>\n<strong>7. Industry Risk Analysis<\/strong>\n<\/p>\n<p>\n<strong>8. Analysis on Treatment Type<\/strong>\n<\/p>\n<p>\n<strong>9. Epidemiology Analysis<\/strong>\n<\/p>\n<p>\n<strong>10. R&amp;D Pipeline Analysis<\/strong>\n<\/p>\n<p>\n<strong>11. Proportion of Healthcare Expenditure (%) by Category and Blood Disorder Type, 2021<\/strong>\n<\/p>\n<p>\n<strong>12. Analysis on the Existing Drug in the Market<\/strong>\n<\/p>\n<p>\n<strong>13. Competitive Positioning<\/strong>\n<\/p>\n<p>\n<strong>14. Competitive Structure<\/strong>\n<\/p>\n<p>\n<strong>15. Global Non-Cancerous Blood Disease Market<\/strong>\n<\/p>\n<p>\n<strong>16. North America Non-Cancerous Blood Disease Market<\/strong>\n<\/p>\n<p>\n<strong>17. Europe Non-Cancerous Blood Disease Market<\/strong>\n<\/p>\n<p>\n<strong>18. Asia Pacific Non-Cancerous Blood Disease Market<\/strong>\n<\/p>\n<p>\n<strong>19. Latin America Non-Cancerous Blood Disease Market<\/strong>\n<\/p>\n<p>\n<strong>20. Middle East &amp; Africa Non-Cancerous Blood Disease Market<\/strong>\n<\/p>\n<p>\n<strong>21. Primary Interview Analysis<\/strong>\n<\/p>\n<p>\n<strong>22. Secondary Research Analysis<\/strong>\n<\/p>\n<p>\n<strong>23. Methodology: Global Non-Cancerous Blood Disease Market<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nSANOFI\n<\/li>\n<li>\nNovo Nordisk A\/S\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nAlexion Pharmaceuticals Inc.\n<\/li>\n<li>\nBayer AG\n<\/li>\n<li>\nBristol Myers Squibb Company\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd.\n<\/li>\n<li>\nTakeda Pharmaceutical Company Limited\n<\/li>\n<li>\nCSL Behring\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624593\/global-non-cancerous-blood-disease-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f2z27n&amp;utm_campaign=1765630+-+Global+Non-Cancerous+Blood+Disease+Market+Report+2022%3A+Growing+Need+for+the+Early+Diagnosis+of+Different+Types+of+Non-Cancerous+Blood+Diseases+Driving+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/jw6bkp<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x70;&#x72;&#x65;ss&#64;&#114;&#101;&#x73;&#x65;&#x61;&#x72;&#x63;ha&#110;&#100;&#109;&#x61;&#x72;&#x6b;&#x65;&#x74;s&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;&#x73;&#64;&#114;&#x65;&#x73;&#x65;a&#114;&#x63;&#x68;&#x61;n&#100;&#x6d;&#x61;&#x72;k&#101;&#x74;&#x73;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Non-Cancerous Blood Disease Market Analysis 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global non-cancerous blood disease market is anticipated to grow with a CAGR of 6.40% over the forecast period, 2022 &#8211; 2031. Factors such as the growing need for the early diagnosis of different types of non-cancerous blood diseases, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49925","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Non-Cancerous Blood Disease Market Analysis 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global non-cancerous blood disease market is anticipated to grow with a CAGR of 6.40% over the forecast period, 2022 &#8211; 2031. Factors such as the growing need for the early diagnosis of different types of non-cancerous blood diseases, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-21T16:02:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-21T16:02:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/\"},\"wordCount\":528,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005383\\\/en\\\/1610256\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/\",\"name\":\"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005383\\\/en\\\/1610256\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-21T16:02:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005383\\\/en\\\/1610256\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005383\\\/en\\\/1610256\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Non-Cancerous Blood Disease Market Analysis 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global non-cancerous blood disease market is anticipated to grow with a CAGR of 6.40% over the forecast period, 2022 &#8211; 2031. Factors such as the growing need for the early diagnosis of different types of non-cancerous blood diseases, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-21T16:02:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector &#8211; ResearchAndMarkets.com","datePublished":"2022-10-21T16:02:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/"},"wordCount":528,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/","name":"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/21\/logo.jpg","datePublished":"2022-10-21T16:02:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221021005383\/en\/1610256\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-non-cancerous-blood-disease-market-report-2022-growing-need-for-the-early-diagnosis-of-different-types-of-non-cancerous-blood-diseases-driving-sector-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Non-Cancerous Blood Disease Market Report 2022: Growing Need for the Early Diagnosis of Different Types of Non-Cancerous Blood Diseases Driving Sector &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49925"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49925\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}